Forum Replies Created
- Replies
-
-
- December 21, 2012 at 4:42 pm
Thanks for all the input– I just updated my dad's profile. I regret how long its taken me to respond to your very helpful comments– everything has just been so hectic since my dad's recurrence.
Right now he is stage IV with the mets concentrated in his neck (both sides and therefore inoperable). This is his first recurrance since initial diagnosis and surgery to remove in 2009. Given his complications we still trying to find the right treatment center for him.
OSU recommended starting with Temodar and Abraxane in hopes that the Zelboraf +MEK inhibitors combo would be available to him in the future
Moffitt suggested going straight to Zelboraf (without the MEK inhibitors). This seems like a bit of a calculated risk given that Zelboraf only works for a limited amount of time and the MEK inhibitors are less likely to add much once you're already on Zelboraf. what his options are after Zelboraf stops working is completely unclear
both confirmed he is very unlikely to be let into a clinical trial and that immunotherapies were completely out.
Next step is Sloan Kettering. Is there anything i should be thinking about or asking about? option just seem so limited.
thanks again,
Naomi -
- December 21, 2012 at 4:42 pm
Thanks for all the input– I just updated my dad's profile. I regret how long its taken me to respond to your very helpful comments– everything has just been so hectic since my dad's recurrence.
Right now he is stage IV with the mets concentrated in his neck (both sides and therefore inoperable). This is his first recurrance since initial diagnosis and surgery to remove in 2009. Given his complications we still trying to find the right treatment center for him.
OSU recommended starting with Temodar and Abraxane in hopes that the Zelboraf +MEK inhibitors combo would be available to him in the future
Moffitt suggested going straight to Zelboraf (without the MEK inhibitors). This seems like a bit of a calculated risk given that Zelboraf only works for a limited amount of time and the MEK inhibitors are less likely to add much once you're already on Zelboraf. what his options are after Zelboraf stops working is completely unclear
both confirmed he is very unlikely to be let into a clinical trial and that immunotherapies were completely out.
Next step is Sloan Kettering. Is there anything i should be thinking about or asking about? option just seem so limited.
thanks again,
Naomi -
- December 21, 2012 at 4:42 pm
Thanks for all the input– I just updated my dad's profile. I regret how long its taken me to respond to your very helpful comments– everything has just been so hectic since my dad's recurrence.
Right now he is stage IV with the mets concentrated in his neck (both sides and therefore inoperable). This is his first recurrance since initial diagnosis and surgery to remove in 2009. Given his complications we still trying to find the right treatment center for him.
OSU recommended starting with Temodar and Abraxane in hopes that the Zelboraf +MEK inhibitors combo would be available to him in the future
Moffitt suggested going straight to Zelboraf (without the MEK inhibitors). This seems like a bit of a calculated risk given that Zelboraf only works for a limited amount of time and the MEK inhibitors are less likely to add much once you're already on Zelboraf. what his options are after Zelboraf stops working is completely unclear
both confirmed he is very unlikely to be let into a clinical trial and that immunotherapies were completely out.
Next step is Sloan Kettering. Is there anything i should be thinking about or asking about? option just seem so limited.
thanks again,
Naomi
-